{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:46:46Z","timestamp":1790714806724,"version":"4.1.0"},"reference-count":226,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CNS"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.toxicon.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T13:38:34Z","timestamp":1581428314000},"page":"20-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Neuronal selectivity of botulinum neurotoxins"],"prefix":"10.1016","volume":"178","author":[{"given":"Bernard","family":"Poulain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Lemichez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2020.02.006_bib1","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/00001756-200312020-00009","article-title":"Mechanisms of secretion of ATP from cortical astrocytes triggered by uridine triphosphate","volume":"14","author":"Abdipranoto","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.toxicon.2020.02.006_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fnmol.2018.00435","article-title":"Synaptic functions of hemichannels and pannexons: a double-edged sword","volume":"11","author":"Abudara","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib3","first-page":"159","article-title":"Synaptic vesicle proteins: targets and routes for botulinum neurotoxins","volume":"364","author":"Ahnert-Hilger","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-5793(89)80478-8","article-title":"The tetanus toxin light chain inhibits exocytosis","volume":"242","author":"Ahnert-Hilger","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.toxicon.2010.07.015","article-title":"Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses","volume":"56","author":"Akaike","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib6","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.toxicon.2020.02.006_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1523\/JNEUROSCI.20-02-00666.2000","article-title":"SNARE protein-dependent glutamate release from astrocytes","volume":"20","author":"Araque","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxicon.2020.02.006_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/head.12185","article-title":"OnabotulinumtoxinA for the treatment of headache","volume":"53","author":"Ashkenazi","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2020.02.006_bib13","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1471-4159.1988.tb02482.x","article-title":"Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes","volume":"50","author":"Ashton","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","article-title":"Central origin of the antinociceptive action of botulinum toxin type A","volume":"94","author":"Bach-Rojecky","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.toxicon.2020.02.006_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.toxicon.2009.01.040","article-title":"Association of botulinum neurotoxins with synaptic vesicle protein complexes","volume":"54","author":"Baldwin","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxicon.2020.02.006_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnmol.2017.00148","article-title":"Puzzling out synaptic vesicle 2 family members functions","volume":"10","author":"Bartholome","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12732","article-title":"Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A","volume":"505","author":"Benoit","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2020.02.006_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1083\/jcb.103.2.521","article-title":"Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves","volume":"103","author":"Black","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1083\/jcb.103.2.535","article-title":"Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis","volume":"103","author":"Black","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(87)90094-7","article-title":"Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems","volume":"23","author":"Black","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2020.02.006_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinids\/1.4.663","article-title":"Absorption of botulinal toxin from the gastrointestinal tract","volume":"1","author":"Bonventre","year":"1979","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.toxicon.2020.02.006_bib23","doi-asserted-by":"crossref","first-page":"F486","DOI":"10.1152\/ajprenal.00314.2005","article-title":"beta-NAD is a novel nucleotide released on stimulation of nerve terminals in human urinary bladder detrusor muscle","volume":"290","author":"Breen","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib24","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1021\/bi050262j","article-title":"2.3 A crystal structure of tetanus neurotoxin light chain","volume":"44","author":"Breidenbach","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2020.02.006_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1873-3468.12969","article-title":"Identification of a novel botulinum neurotoxin gene cluster in enterococcus","volume":"592","author":"Brunt","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1083\/jcb.100.4.1284","article-title":"Identification of a transmembrane glycoprotein specific for secretory vesicles of neuronal and endocrine cells","volume":"100","author":"Buckley","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib27","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1523\/JNEUROSCI.22-16-06876.2002","article-title":"Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function","volume":"22","author":"Bullens","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction","volume":"109","author":"Burgen","year":"1949","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2017.10.027","article-title":"Direct central nervous system effects of botulinum neurotoxin","volume":"147","author":"Caleo","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1967.sp008119","article-title":"Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats","volume":"188","author":"Carpenter","year":"1967","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","article-title":"Drug Insight: biological effects of botulinum toxin A in the lower urinary tract","volume":"5","author":"Chancellor","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib32","first-page":"S19","article-title":"Neurophysiology of stress urinary incontinence","volume":"6","author":"Chancellor","year":"2004","journal-title":"Rev. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.biochem.77.062005.101135","article-title":"How does synaptotagmin trigger neurotransmitter release?","volume":"77","author":"Chapman","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00187137","article-title":"Differential permeability of blood microvasculatures in various sympathetic ganglia of rodents","volume":"194","author":"Chau","year":"1996","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fncel.2014.00405","article-title":"Neuronal involvement in muscular atrophy","volume":"8","author":"Cisterna","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.juro.2011.10.130","article-title":"Effect of onabotulinumtoxinA on intramural parasympathetic ganglia: an experimental study in the Guinea pig bladder","volume":"187","author":"Coelho","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib37","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.eururo.2012.01.046","article-title":"Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action","volume":"61","author":"Coelho","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.eururo.2009.12.022","article-title":"Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder","volume":"57","author":"Coelho","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.expneurol.2016.05.029","article-title":"Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats","volume":"285","author":"Coelho","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib40","first-page":"513","article-title":"Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis","volume":"23","author":"Coelho","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.toxicon.2020.02.006_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8423-9","article-title":"Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction","volume":"48","author":"Colasante","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/cmi.12502","article-title":"Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall","volume":"18","author":"Connan","year":"2016","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12738","article-title":"Botulinum neurotoxin type B uses a distinct entry pathway mediated by Cdc42 into intestinal cells versus neuronal cells","volume":"19","author":"Connan","year":"2017","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib44","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41467-019-10732-w","article-title":"A neurotoxin that specifically targets Anopheles mosquitoes","volume":"10","author":"Contreras","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002583","article-title":"Preferential entry of botulinum neurotoxin A Hc domain trhough intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine","volume":"8","author":"Couesnon","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2020.02.006_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1462-5822.2008.01253.x","article-title":"Differential entry of botulinum neurotoxin A into neuronal and intestinal cells","volume":"11","author":"Couesnon","year":"2009","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2020.02.006_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2010.09.063","article-title":"Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system","volume":"1367","author":"Dardou","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.toxicon.2020.02.006_bib49","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41598-017-01198-1","article-title":"Affinity biosensors using recombinant native membrane proteins displayed on exosomes: application to botulinum neurotoxin B receptor","volume":"7","author":"Desplantes","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2020.02.006_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.38.4.327","article-title":"Botulism. Studies on the manner in which the toxin of Clostridium botulinum acts upon the body : ii. The effect upon the voluntary nervous system","volume":"38","author":"Dickson","year":"1923","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.toxicon.2020.02.006_bib51","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ane.12906","article-title":"Botulinum toxin: a review of the mode of action in migraine","volume":"137","author":"Do","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.toxicon.2020.02.006_bib52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","article-title":"Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization","volume":"307","author":"Dolly","year":"1984","journal-title":"Nature (London)"},{"key":"10.1016\/j.toxicon.2020.02.006_bib53","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.e08-07-0765","article-title":"Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.toxicon.2020.02.006_bib54","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.toxicon.2020.02.006_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular characterization of a novel botulinum neurotoxin type H gene","volume":"209","author":"Dover","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxicon.2020.02.006_bib56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00415-012-6615-2","article-title":"Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system","volume":"260","author":"Dressler","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib57","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/09638280701568296","article-title":"Pharmacology of therapeutic botulinum toxin preparations","volume":"29","author":"Dressler","year":"2007","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.toxicon.2020.02.006_bib58","doi-asserted-by":"crossref","first-page":"34846","DOI":"10.1074\/jbc.M202902200","article-title":"Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin","volume":"277","author":"Duggan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1113\/jphysiol.1987.sp016514","article-title":"Botulinum toxin inhibits quantal acetylcholine release and energy metabolism in the Torpedo electric organ","volume":"385","author":"Dunant","year":"1987","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2017.12.029","article-title":"Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain","volume":"1702","author":"Dunn","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.toxicon.2020.02.006_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2020.02.006_bib62","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.clinph.2012.11.004","article-title":"Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study","volume":"124","author":"Eleopra","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau7196","article-title":"Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models","volume":"5","author":"Elliott","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.toxicon.2020.02.006_bib64","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1074\/jbc.275.12.8889","article-title":"The structures of the Hc fragment of Tetanus Toxin with carbohydrate subunit complexes provide insight into ganglioside binding","volume":"275","author":"Emsley","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxicon.2017.05.001","article-title":"Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain","volume":"133","author":"Fan","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib66","first-page":"134","article-title":"Infant botulism","volume":"45","author":"Fenicia","year":"2009","journal-title":"Ann. Ist. Super Sanita"},{"key":"10.1016\/j.toxicon.2020.02.006_bib67","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/bc4003103","article-title":"Synthetic self-assembling clostridial chimera for modulation of sensory functions","volume":"24","author":"Ferrari","year":"2013","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029803","article-title":"Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy","volume":"7","author":"Filipovic","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.toxicon.2020.02.006_bib69","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib70","doi-asserted-by":"crossref","first-page":"18098","DOI":"10.1073\/pnas.1908051116","article-title":"Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B","volume":"116","author":"Flores","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2020.02.006_bib71","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E and F compared with the long lasting type A","volume":"278","author":"Foran","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib72","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1074\/jbc.M103285200","article-title":"The crystal structure of Tetanus Toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin","volume":"276","author":"Fotinou","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pediatrneurol.2004.10.001","article-title":"Recent advances in infant botulism","volume":"32","author":"Fox","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib74","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1021\/bi9002138","article-title":"Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype","volume":"48","author":"Fu","year":"2009","journal-title":"F. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib75","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1021\/bi060786z","article-title":"Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate","volume":"45","author":"Fu","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2020.02.006_bib76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.toxicon.2017.10.020","article-title":"Translocation and dissemination of botulinum neurotoxin from the intestinal tract","volume":"147","author":"Fujinaga","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","article-title":"The enteric nervous system and gastrointestinal innervation: integrated local and central control","volume":"817","author":"Furness","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","article-title":"5-Hydroxytryptamine (serotonin) in the gastrointestinal tract","volume":"20","author":"Gershon","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.toxicon.2020.02.006_bib79","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.toxicon.2020.02.006_bib80","first-page":"93","article-title":"Clostridial neurotoxins: handling and action at the cellular and molecular level","volume":"129","author":"Habermann","year":"1986","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000317517","article-title":"The unusual history and the urological applications of botulinum neurotoxin","volume":"85","author":"Hanchanale","year":"2010","journal-title":"Urol. Int."},{"key":"10.1016\/j.toxicon.2020.02.006_bib82","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0960-8966(94)90089-2","article-title":"Calcitonin gene-related peptide-like immunoreactivity, in botulinum toxin-paralysed rat muscles","volume":"4","author":"Hassan","year":"1994","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.toxicon.2020.02.006_bib83","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.72.7.2520","article-title":"Interaction of cholera toxin and membrane GM1 ganglioside of small intestine","volume":"72","author":"Holmgren","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2020.02.006_bib84","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.toxicon.2020.02.006_bib85","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.eururo.2012.03.031","article-title":"Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder","volume":"62","author":"Ikeda","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib86","first-page":"2239","article-title":"Effects of botulinum toxin type D on secretion of tumor necrosis factor from human monocytes","volume":"9","author":"Imamura","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib87","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/oxfordjournals.jbchem.a134667","article-title":"Gangliosides of various rat tissues: distribution of ganglio-N-tetraose-containing gangliosides and tissue-characteristic composition of gangliosides","volume":"95","author":"Iwamori","year":"1984","journal-title":"J. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11320","article-title":"Molecular machines governing exocytosis of synaptic vesicles","volume":"490","author":"Jahn","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2020.02.006_bib89","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: state of the art","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2020.02.006_bib90","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0306-4522(99)00370-X","article-title":"SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family","volume":"94","author":"Janz","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2020.02.006_bib91","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity","volume":"444","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2020.02.006_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-4165(93)90138-X","article-title":"Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin","volume":"1156","author":"Kamata","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2020.02.006_bib93","doi-asserted-by":"crossref","first-page":"40806","DOI":"10.1074\/jbc.M112.404244","article-title":"Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry","volume":"287","author":"Karalewitz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib94","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1021\/bi100865f","article-title":"Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA","volume":"49","author":"Karalewitz","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2020.02.006_bib95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0029(19961001)35:2<122::AID-JEMT3>3.0.CO;2-S","article-title":"Vascular permeability in the peripheral autonomic and somatic nervous systems: controversial aspects and comparisons with the blood-brain barrier","volume":"35","author":"Kiernan","year":"1996","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.toxicon.2020.02.006_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(99)00140-7","article-title":"Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice","volume":"1441","author":"Kitamura","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2020.02.006_bib97","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.neuroscience.2009.01.066","article-title":"Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction","volume":"159","author":"Kitamura","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2020.02.006_bib98","doi-asserted-by":"crossref","first-page":"506160","DOI":"10.5402\/2012\/506160","article-title":"Ganglioside biochemistry","volume":"2012","author":"Kolter","year":"2012","journal-title":"ISRN Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib99","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1111\/j.1742-4658.2011.08166.x","article-title":"Unique ganglioside binding by botulinum neurotoxins C and D-SA","volume":"278","author":"Kroken","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib100","doi-asserted-by":"crossref","first-page":"26828","DOI":"10.1074\/jbc.M111.254086","article-title":"Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons","volume":"286","author":"Kroken","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib102","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the clostridial neurotoxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib103","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib104","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/jpet.110.169342","article-title":"Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers","volume":"334","author":"Lawrence","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.toxicon.2020.02.006_bib105","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.1253823","article-title":"Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex","volume":"344","author":"Lee","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.toxicon.2020.02.006_bib106","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1523\/JNEUROSCI.6684-10.2011","article-title":"Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development\/survival of enteric dopaminergic neurons","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib107","first-page":"63","article-title":"Bladder paralysis due to foodborne botulinum toxin type B","volume":"7","author":"Loiseau","year":"2010","journal-title":"Urol. J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib108","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/bs.pmbts.2018.03.001","article-title":"Gangliosides in axon stability and regeneration","volume":"156","author":"Lopez","year":"2018","journal-title":"Prog. Mol. Bio.Trans. Sci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib109","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.toxicon.2020.02.006_bib110","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves","volume":"580","author":"Mahrhold","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20130391","article-title":"Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type","volume":"453","author":"Mahrhold","year":"2013","journal-title":"E. Biochem. J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib112","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1432-1033.1988.tb14422.x","article-title":"Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release","volume":"177","author":"Maisey","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib113","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1128\/IAI.67.9.4708-4712.1999","article-title":"Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade","volume":"67","author":"Maksymowych","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib114","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/j.pain.0000000000000478","article-title":"Nonparalytic botulinum molecules for the control of pain","volume":"157","author":"Mangione","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2020.02.006_bib115","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41598-018-37647-8","article-title":"Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins","volume":"9","author":"Mansfield","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2020.02.006_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047977","article-title":"The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes","volume":"7","author":"Marinelli","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.toxicon.2020.02.006_bib117","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.15252\/embr.201744198","article-title":"The structure of the tetanus toxin reveals pH-mediated domain dynamics","volume":"18","author":"Masuyer","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.toxicon.2020.02.006_bib118","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.pain.2014.04.027","article-title":"Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons","volume":"155","author":"Matak","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2020.02.006_bib119","first-page":"355","article-title":"The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption","volume":"10","author":"Matsumura","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib120","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1038\/ncomms7255","article-title":"Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity","volume":"6","author":"Matsumura","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib121","first-page":"307","article-title":"The absorption of Clostridium botulinum type Atoxin from the alimentary canal","volume":"39","author":"May","year":"1958","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib122","doi-asserted-by":"crossref","first-page":"21338","DOI":"10.1016\/S0021-9258(19)36614-1","article-title":"Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action","volume":"267","author":"McMahon","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib123","article-title":"Selective cleavage of SNAREs in sensory neurons unveils protein complexes mediating peptide exocytosis triggered by different stimuli","volume":"8","author":"Meng","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib124","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10286-003-0118-2","article-title":"Botulism type B presenting as pure autonomic dysfunction","volume":"13","author":"Merz","year":"2003","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.toxicon.2020.02.006_bib125","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1007\/BF02346386","article-title":"Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin","volume":"431","author":"Meunier","year":"1996","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.toxicon.2020.02.006_bib126","first-page":"152","article-title":"Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions","volume":"84","author":"Molgo","year":"1990","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.toxicon.2020.02.006_bib127","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0968-0004(86)90282-3","article-title":"How do tetanus and botulinum toxins to neuronal membranes?","volume":"11","author":"Montecucco","year":"1986","journal-title":"TIBS (Trends Biochem. Sci.)"},{"key":"10.1016\/j.toxicon.2020.02.006_bib129","doi-asserted-by":"crossref","first-page":"H2627","DOI":"10.1152\/ajpheart.00477.2002","article-title":"Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons","volume":"283","author":"Morris","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib130","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1046\/j.1471-4159.1999.0721991.x","article-title":"Clostridium neurotoxins influence serotonin uptake and release differently in rat brain synaptosomes","volume":"72","author":"Najib","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxicon.2012.10.020","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders","volume":"67","author":"Naumann","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib132","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1083\/jcb.147.6.1249","article-title":"Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal","volume":"147","author":"Neale","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib133","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1016\/S0021-9258(17)34087-5","article-title":"Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes","volume":"269","author":"Nishiki","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib134","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(95)01471-3","article-title":"The high-affinity of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1B\/GD1a","volume":"378","author":"Nishiki","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/oxfordjournals.jbchem.a121702","article-title":"Binding of Clostridium botulinum neurotoxin to gangliosides","volume":"100","author":"Ochanda","year":"1986","journal-title":"J. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib136","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1523\/JNEUROSCI.3519-06.2006","article-title":"Synaptotagmin-2 is essential for survival and contributes to Ca2+ triggering of neurotransmitter release in central and neuromuscular synapses","volume":"26","author":"Pang","year":"2006","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.toxicon.2020.02.006_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxicon.2020.02.006_bib138","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/toxins9010038","article-title":"Historical perspectives and guidelines for botulinum neurotoxin subtype nomenclature","volume":"9","author":"Peck","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.toxicon.2020.02.006_bib139","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00100-15","article-title":"Purification and characterization of botulinum neurotoxin FA from a genetically modified Clostridium botulinum strain","volume":"1","author":"Pellett","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.toxicon.2020.02.006_bib140","article-title":"Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations","volume":"13508","author":"Pellett","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib141","first-page":"3233","article-title":"Botulinum neurotoxin D-C uses synaptotagmin I\/II as receptors and human synaptotagmin II is not an effective receptor for type B, D-C, and G toxins","volume":"125","author":"Peng","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002008","article-title":"Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors","volume":"7","author":"Peng","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2020.02.006_bib143","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/324076a0","article-title":"Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells","volume":"324","author":"Penner","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2020.02.006_bib144","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17460441.2017.1303476","article-title":"Challenges in searching for therapeutics against botulinum neurotoxins","volume":"12","author":"Pirazzini","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.toxicon.2020.02.006_bib145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxicon.2020.02.006_bib146","series-title":"Molecular Aspects of Botulinum Neurotoxin","first-page":"35","article-title":"Absorption and transport of botulinum neurotoxins","author":"Popoff","year":"2014"},{"key":"10.1016\/j.toxicon.2020.02.006_bib147","series-title":"The Comprehensive Sourcebook of Bacterial Protein Toxins","first-page":"174","article-title":"Structural and genomic features of clostridial neurotoxins","author":"Popoff","year":"1999"},{"key":"10.1016\/j.toxicon.2020.02.006_bib148","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/toxins2040683","article-title":"Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells","volume":"2","author":"Popoff","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxicon.2020.02.006_bib149","first-page":"243","article-title":"Quantal neurotransmitter release and the clostridial neurotoxins' targets","volume":"195","author":"Poulain","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.toxicon.2020.02.006_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11010034","article-title":"Why are botulinum neurotoxin-producing bacteria so diverse and botulinum neurotoxins so toxic?","volume":"11","author":"Poulain","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.toxicon.2020.02.006_bib151","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1504\/TBJ.2008.018951","article-title":"How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action","volume":"1","author":"Poulain","year":"2008","journal-title":"Botulinum J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib152","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1073\/pnas.85.11.4090","article-title":"Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain","volume":"85","author":"Poulain","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2020.02.006_bib153","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/bph.12763","article-title":"Therapeutic use of botulinum toxin in migraine: mechanisms of action","volume":"171","author":"Ramachandran","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib154","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","article-title":"Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder","volume":"175","author":"Rapp","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib155","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1002\/j.1460-2075.1996.tb01087.x","article-title":"Mutational analysis of VAMP domains implicated in Ca2+-induced insulin exocytosis","volume":"15","author":"Regazzi","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003087","article-title":"Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons","volume":"8","author":"Restani","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2020.02.006_bib157","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1600-0854.2012.01369.x","article-title":"Botulinum neurotoxin a impairs neurotransmission following retrograde transynaptic transport","volume":"13","author":"Restani","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.toxicon.2020.02.006_bib158","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.hrthm.2018.08.019","article-title":"Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: three-year follow-up of a randomized study","volume":"16","author":"Romanov","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.toxicon.2020.02.006_bib159","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2020.02.006_bib160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-1331.2010.03056.x","article-title":"On muscle spindles, dystonia and botulinum toxin","volume":"17","author":"Rosales","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib161","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pediatrneurol.2015.01.006","article-title":"Infant botulism: review and clinical update","volume":"52","author":"Rosow","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib162","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2017.10.010","article-title":"The binding of botulinum neurotoxins to different peripheral neurons","volume":"147","author":"Rossetto","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib163","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.toxicon.2015.07.002","article-title":"Current gaps in basic science knowledge of botulinum neurotoxin biological actions","volume":"107","author":"Rossetto","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib164","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.toxicon.2012.12.027","article-title":"Tetanus neurotoxin","volume":"66","author":"Rossetto","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib165","first-page":"1","article-title":"Two feet on the membrane: uptake of clostridial neurotoxins","volume":"406","author":"Rummel","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib166","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0609713104","article-title":"Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept","volume":"104","author":"Rummel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2020.02.006_bib167","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","article-title":"Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor","volume":"110","author":"Rummel","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib168","doi-asserted-by":"crossref","first-page":"30865","DOI":"10.1074\/jbc.M403945200","article-title":"Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G","volume":"279","author":"Rummel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib169","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The Hcc-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"Rummel","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib170","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.toxicon.2020.02.006_bib171","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","article-title":"Botulinum toxin treatment of pain syndromes -an evidence based review","volume":"147","author":"Safarpour","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib172","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1523\/JNEUROSCI.15-01-00520.1995","article-title":"Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions","volume":"15","author":"Sala","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.006_bib173","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1432-1033.1987.tb11494.x","article-title":"Botulinum toxin A blocks glutamate exocytosis from Guinea-pig cerebral cortical synaptosomes","volume":"165","author":"Sanchez-Prieto","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib174","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000052513","article-title":"Transient paralysis of the bladder due to wound botulism","volume":"39","author":"Sautter","year":"2001","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib175","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.jmb.2016.05.020","article-title":"Gangliosides of the vertebrate nervous system","volume":"428","author":"Schnaar","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib176","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.accb.2018.09.002","article-title":"The biology of gangliosides","volume":"76","author":"Schnaar","year":"2019","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib177","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.toxicon.2020.02.006_bib178","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1464-410X.2007.07137.x","article-title":"Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment","volume":"100","author":"Schulte-Baukloh","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.toxicon.2020.02.006_bib179","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.toxicon.2020.02.006_bib180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A","volume":"48","author":"Shimizu","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.toxicon.2020.02.006_bib181","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","volume":"68","author":"Simpson","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib182","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxicon.2020.02.006_bib183","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1471-4159.1971.tb00235.x","article-title":"Ganglioside inactivation of botulinum toxin","volume":"18","author":"Simpson","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib184","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection: type B compared with type A","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2020.02.006_bib185","series-title":"The Comprehensive Sourcebook of Bacterial Protein Toxins","first-page":"1019","article-title":"Bacterial protein toxins as biological weapons","author":"Smith","year":"2006"},{"key":"10.1016\/j.toxicon.2020.02.006_bib186","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"Smith","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib187","doi-asserted-by":"crossref","first-page":"H1818","DOI":"10.1152\/ajpheart.01062.2005","article-title":"Nicotinamide adenine dinucleotide is released from sympathetic nerve terminals via a botulinum neurotoxin A-mediated mechanism in canine mesenteric artery","volume":"290","author":"Smyth","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib188","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.toxicon.2020.02.006_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000129","article-title":"Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction","volume":"4","author":"Stenmark","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2020.02.006_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007048","article-title":"A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency","volume":"14","author":"Stern","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.toxicon.2020.02.006_bib191","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2958.2011.07682.x","article-title":"The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites","volume":"81","author":"Strotmeier","year":"2011","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib192","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/BJ20101042","article-title":"Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner","volume":"431","author":"Strotmeier","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib193","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.febslet.2014.02.034","article-title":"Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A","volume":"588","author":"Strotmeier","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib194","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","article-title":"Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity","volume":"586","author":"Strotmeier","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2020.02.006_bib195","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200910119","article-title":"Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin","volume":"189","author":"Sugawara","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib196","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxicon.2017.10.008","article-title":"The travel diaries of tetanus and botulinum neurotoxins","volume":"147","author":"Surana","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib197","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0005-2760(94)90034-5","article-title":"Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord","volume":"1214","author":"Svennerholm","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2020.02.006_bib198","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1111\/j.1742-4658.2011.08183.x","article-title":"Molecular structures and functional relationships in clostridial neurotoxins","volume":"278","author":"Swaminathan","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib199","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2004.07.030","article-title":"Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin","volume":"51","author":"Swartling","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib201","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-017-00064-y","article-title":"Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors","volume":"8","author":"Tao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.toxicon.2012.11.011","article-title":"Botulinum neurotoxins: mechanism of action","volume":"67","author":"Tighe","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib203","doi-asserted-by":"crossref","first-page":"35164","DOI":"10.1074\/jbc.M507596200","article-title":"Binding of Clostridium botulinum types C and D neurotoxins to ganglioside and phospholipid","volume":"280","author":"Tsukamoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib204","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsb1097-788","article-title":"The structure of the receptor binding fragment Hc of tetanus neurotoxin","volume":"4","author":"Umland","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib205","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1073\/pnas.87.2.553","article-title":"Acetylcholine and ATP are coreleased from the electromotor nerve terminals of Narcine brasiliensis by an exocytotic mechanism","volume":"87","author":"Unsworth","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2020.02.006_bib206","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075720","article-title":"Differential distribution of major brain gangliosides in the adult mouse central nervous system","volume":"8","author":"Vajn","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.toxicon.2020.02.006_bib207","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/00221287-24-1-107","article-title":"The fixation of tetanus toxin by ganglioside","volume":"24","author":"Van Heyningen","year":"1961","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib208","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.1999.0730372.x","article-title":"Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes","volume":"73","author":"Verderio","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib209","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0854.2006.00520.x","article-title":"Traffic of botulinum toxins A and E in excitatory and inhibitory neurons","volume":"8","author":"Verderio","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.toxicon.2020.02.006_bib210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0896-6273(04)00077-7","article-title":"SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization","volume":"41","author":"Verderio","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.toxicon.2020.02.006_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11010021","article-title":"Central effects of botulinum neurotoxin-evidence from human studies","volume":"11","author":"Weise","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.toxicon.2020.02.006_bib212","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8050154","article-title":"Botulinum neurotoxin serotype A recognizes its protein receptor SV2 by a different mechanism than botulinum neurotoxin B synaptotagmin","volume":"8","author":"Weisemann","year":"2016","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.toxicon.2020.02.006_bib213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.006_bib214","series-title":"Selective Neurotoxicity","first-page":"357","article-title":"Tetanus and botulinum neurotoxins","author":"Wellh\u00f6ner","year":"1992"},{"key":"10.1016\/j.toxicon.2020.02.006_bib215","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01296-17","article-title":"Closed genome sequence of Chryseobacterium piperi strain CTM(T)\/ATCC BAA-1782, a gram-negative bacterium with clostridial neurotoxin-like coding sequences","volume":"5","author":"Wentz","year":"2017","journal-title":"Genome Announc."},{"key":"10.1016\/j.toxicon.2020.02.006_bib216","article-title":"Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity","volume":"17","author":"Willjes","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2020.02.006_bib217","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj1560701","article-title":"Inhibition by botulinum toxin of depolarization-evoked release of (14C)acetylcholine from synaptosomes in vitro","volume":"156","author":"Wonnacott","year":"1976","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2020.02.006_bib218","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1526-4637.2011.01182.x","article-title":"Botulinum toxin decreases hyperalgesia and inhibits P2X3 receptor over-expression in sensory neurons induced by ventral root transection in rats","volume":"12","author":"Xiao","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.toxicon.2020.02.006_bib219","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nsmb.3245","article-title":"N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A","volume":"23","author":"Yao","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.toxicon.2020.02.006_bib220","first-page":"347","article-title":"Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons","volume":"4","author":"Yiangou","year":"2011","journal-title":"J. Pain Res."},{"key":"10.1016\/j.toxicon.2020.02.006_bib221","doi-asserted-by":"crossref","first-page":"32815","DOI":"10.1074\/jbc.M205258200","article-title":"Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I","volume":"277","author":"Yowler","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2020.02.006_bib222","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41467-017-01534-z","article-title":"Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib223","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2017.12.018","article-title":"Identification of a botulinum neurotoxin-like toxin in a commensal strain of Enterococcus faecium","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.toxicon.2020.02.006_bib224","doi-asserted-by":"crossref","first-page":"14130","DOI":"10.1038\/ncomms14130","article-title":"Identification and characterization of a novel botulinum neurotoxin","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib225","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2010.09.063","article-title":"Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D","volume":"401","author":"Zhang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxicon.2020.02.006_bib226","doi-asserted-by":"crossref","first-page":"30257","DOI":"10.1038\/srep30257","article-title":"The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain","volume":"6","author":"Zornetta","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010120300374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010120300374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:14:09Z","timestamp":1758575649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010120300374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":226,"alternative-id":["S0041010120300374"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2020.02.006","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal selectivity of botulinum neurotoxins","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}